FDA's Linda Carter
Executive Summary
Office of Drug Evaluation I deputy director is on six-month detail in Rep. Steve Gunderson's (R-Wisc.) office working on issues including health care financing reform, under the aegis of the federal LEGISfellows program. Division of Antiviral Drugs Consumer Safety Officer David Rosen temporarily has taken over Carter's ODEI responsibilities....